Poor prognosis of drug‐induced and acute graft‐versus‐host disease‐induced epidermal necrolysis in bone marrow/stem cell transplant recipients: a retrospective case series
- 1 June 2020
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (9), E506-E510
- https://doi.org/10.1111/jdv.16421
Abstract
Toxic epidermal necrolysis (TEN) and stage IV acute graft-versus-host disease (AGVHD) are uncommon severe complications in bone marrow/hematopoietic stem cell transplant (BMT/HSCT) recipients and are often clinically indistinguishable.1-7 We sought to identify discriminating clinical and pathological features between drug-induced EN (DI-EN) and acute-graft AGVHDI-EN and determine their prognosis.Keywords
This publication has 10 references indexed in Scilit:
- Extensive Toxic Epidermal Necrolysis Versus Acute Graft Versus Host Disease After Allogenic Hematopoietic Stem-Cell TransplantationJournal of Burn Care & Research, 2014
- Risk factors for acute GVHD and survival after hematopoietic cell transplantationBlood, 2012
- Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactionsJournal of the American Academy of Dermatology, 2011
- Stage IV cutaneous acute graft-versus-host disease. Clinical and histological study of 15 casesJournal of the European Academy of Dermatology and Venereology, 2009
- Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantationBone Marrow Transplantation, 2007
- Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panelPharmacoepidemiology and Drug Safety, 2005
- Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipientBone Marrow Transplantation, 2002
- CD8+ Lymphocytes in the Blister Fluid of Severe Acute Cutaneous Graft-versus-Host Disease: Further Similarities with Toxic Epidermal NecrolysisDermatology, 2001
- Toxic Epidermal Necrolysis Possibly Linked to Aztreonam in Bone Marrow Transplant PatientsAnnals of Pharmacotherapy, 1992
- Toxic epidermal necrolysis after bone marrow transplantation: Study of nine casesJournal of the American Academy of Dermatology, 1990